Contact & Media

Flow Neuroscience received $9 million in Series A funding to make self-managed medical device available globally

Flow Neuroscience acquires assets of leading neuromodulation company Halo Neuroscience

Flow Neuroscience increases sales in 2020, with 30% of users recovering from depression

Flow depression headset and app to tackle UK’s ‘lockdown loneliness’ as new research links loneliness to worse mental health

Flow depression treatment helps 81% of patients to feel better after three weeks

Mental health startup Flow joins ORCHA App Library

Flow unveils chatbot therapist to combat depression

Clinical Study Evaluating Combined tDCS And Behaviour Therapy Points To A New Treatment For Depression